Literature DB >> 14755657

Comparison of FAIR perfusion kinetics with DSC-MRI and functional histology in a model of transient ischemia.

Janneke Schepers1, Wouter B Veldhuis, Robert-Jan Pauw, Jan-Willem de Groot, Matthias J P van Osch, Klaas Nicolay, Boudewijn P J van der Sanden.   

Abstract

Flow-sensitive alternating inversion recovery (FAIR) is a noninvasive method for perfusion imaging. It has been shown that the FAIR signal may depend on hemodynamic parameters other than perfusion, the most important one being transit delays of labeled spins to the observed tissue. These parameters are expected to change with ischemia. The goal of this study was to assess the effect of these changes on the interpretation of FAIR results in the case of altered perfusion. This was investigated in a rat model of transient cerebral ischemia. It was shown that the ratio of FAIR signal in the infarct compared to the contralateral side was lower at short inflow times, which suggests that transit times affected the effective FAIR signal. The FAIR results were compared with those from functional histology and dynamic susceptibility contrast MRI, and the findings indicated that the altered kinetics of the FAIR signal were related to reduced and delayed inflow in the infarct region--not to a decrease in the number of functional vessels. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14755657     DOI: 10.1002/mrm.10691

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  2 in total

1.  Underestimation of cerebral perfusion on flow-sensitive alternating inversion recovery image: semiquantitative evaluation with time-to-peak values.

Authors:  H S Kim; S Y Kim; J M Kim
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-26       Impact factor: 3.825

2.  Characterization of gadolinium-based dynamic susceptibility contrast perfusion measurements in permanent and transient MCAO models with volumetric based validation by CASL.

Authors:  Bernt T Bråtane; Ronn P Walvick; Claire Corot; Eric Lancelot; Marc Fisher
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-14       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.